SCHEMBL3984436

SCHEMBL3984436

Cc1noc(-c2ccccc2)c1C(C)N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
MAPT P10636 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
BRD4 O60885 2/20 0.46
TDO2 P48775 1/20 0.46
GAA P10253 1/20 0.45
BRD2 P25440 1/20 0.44
LPAR1 Q92633 1/20 0.43
LPAR3 Q9UBY5 1/20 0.43
KDM4E B2RXH2 1/20 0.38
NOTUM Q6P988 1/20 0.37
NPC1 O15118 1/20 0.37
NFKB1 P19838 1/20 0.37
RAB9A P51151 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
PTPN1 P18031 1/20 0.37
TRPA1 O75762 1/20 0.36
PTGS1 P23219 2/20 0.36
PTGS2 P35354 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4762474 0.86 GAA (0.47) ALDH1A1MAPTSMN1; SMN2BRD4TDO2
SCHEMBL27743830 0.83 GAA (0.45) ALDH1A1MAPTSMN1; SMN2BRD4TDO2
SCHEMBL4677465 0.83 ALDH1A1 (0.47) ALDH1A1MAPTSMN1; SMN2BRD4TDO2
SCHEMBL11996614 0.80 GAA (0.42) ALDH1A1MAPTSMN1; SMN2BRD4TDO2
SCHEMBL4263239 0.75 LPAR1 (0.41) ALDH1A1MAPTSMN1; SMN2BRD4TDO2
SCHEMBL1754692 0.74 BRD4 (0.56) ALDH1A1MAPTSMN1; SMN2BRD4TDO2
SCHEMBL3751072 0.74 BRD4 (0.53) ALDH1A1MAPTSMN1; SMN2BRD4TDO2
SCHEMBL21105338 0.72 BRD4 (0.68) ALDH1A1MAPTSMN1; SMN2BRD4TDO2
SCHEMBL13388 0.71 BRD4 (0.53) ALDH1A1MAPTSMN1; SMN2BRD4TDO2
SCHEMBL13197077 0.71 BRD4 (0.43) ALDH1A1MAPTSMN1; SMN2BRD4TDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2059502-A2 PROLINE UREA CCR1 ANTAGONISTS FOR THE TREATMENT OF AUTOIMMUNE DISEASES OR INFLAMMATION LIGAND PHARMACEUTICALS INCORPORATED (US) 2009-05-20 EP disclosed
WO-2008011392-A2 PROLINE UREA CCR1 ANTAGONISTS FOR THE TREATMENT OF AUTOIMMUNE DISEASES OR INFLAMMATION LIGAND PHARMACUETICALS INCORPORATED (US) 2008-01-24 WO disclosed